ACADIA Pharmaceuticals, Inc. (ACAD)
26.89
+0.13
(+0.49%)
USD |
NASDAQ |
Dec 09, 16:00
26.89
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap: 4.549B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 358.72M |
| ADMA Biologics, Inc. | 4.712B |
| Aldeyra Therapeutics, Inc. | 287.28M |
| Amicus Therapeutics, Inc. | 3.025B |
| ANI Pharmaceuticals, Inc. | 1.833B |
Market Cap Related Metrics
| PE Ratio | 17.30 |
| PS Ratio | 4.325 |
| PEG Ratio | 0.1710 |
| Price to Book Value | 4.960 |
| Price to Free Cash Flow | 45.76 |
| Price | 26.89 |
| Earnings Yield | 5.78% |
| PEGY Ratio | 0.1710 |
| Operating PE Ratio | 47.97 |
| Normalized PE Ratio | 17.30 |